Universal Reusable Packaging (UNREPA) – a Swiss company – has successfully passed the tests for the ‘TESTEX Community Mask’ label for Livipro community. The fabric mask is reusable and provides satisfactory protection against viruses and bacteria even after 20 washes by combining the high safety levels of a respirator mask with a hygiene mask.
Together with Empa, TESTEX has refined a test whereby textile masks are being assessed on their filter function, splash resistance, wear comfort, reusability, and additionally, their textile tolerance.
Community masks that have passed these tests based on the recommendations of the Swiss National COVID-19 Science Task Force, are carrying the ‘TESTEX Community Mask’ label. The label gives consumers clarity and at the same time serves as a quality standard for manufacturers, according to a press release by TESTEX.
The textile mask is equipped with three different layers, which protect the wearer from infection. The first layer is used to repel viruses and bacteria and to create the most hostile environment for them as possible.
This is followed by the so-called labyrinth layer, which, due to its complex structure, prevents aerosol droplets from penetrating any further. The last layer again fights off viruses and bacteria, and has an additional integrated nose clip, which ensures that the mask fits perfectly.
Pascal Eggmann, CEO and Owner of UNREPA said, “The Livipro Community Mask was produced as a kind of hybrid form between a respiratory and a hygiene mask. We deliberately opted for this structure and the three-layer structure. This means that the mask can be washed and reused up to 20 times without losing its protective function. We are proud to have achieved the ‘TESTEX Community Mask’ label and to be able to offer our customers an officially tested, high-quality and sustainable protective mask.”
The label is envisioned to create trust and give the general public the opportunity to make a conscious decision in favour of a textile mask which has been tested according to the current recommendations.